fbpx

Discovery Platform
From Target to Market

Discovery Services

Proven Chemistry

Screening Libraries
1.6M Compounds eShop

Pharmaceutical
Development

Pharmaceutical Development

Why Choose ChemDiv?

  • 25 years experience and 2500 customers worldwide
  • Premium R&D CRO based in USA with global reach
  • Seasoned project managers
  • Extensive Academic partnerships
  • Flexible business models
  • Industry's largest ever-greening stock compound inventory
  • Ongoing investments in novel proprietary chemistry and discovery platforms
Learn More About Us

Our News

Viriom Launches Reproductive Toxicity Studies for Elpida® (Elsulfavirine) Once Weekly Oral Formulation
New article “A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling”
ChemRar Announced Successful Completion of Phase II Clinical Trials of AB5080
Read All Our News >

Pharma News

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis
BeiGene’s supply of Bristol Myers Squibb’s Abraxane freezes in China amid Fresenius Kabi plant woes
Jefferies pumping $10M into ApiJect and HHS’ national syringe ‘surge’ network
Read All Pharma News >

New Products &Services

Target Activity profiling library
MCE-18 Trends in MedChem
Covalent Inhibitors library
RNA Trinucleotide mimetics
Share this: